Antineoplastic therapy after discontinuation of sonidegib 200 mg in patients with advanced basal cell carcinoma: Results from the 42-month, randomized, double-blind BOLT study Gutzmer, R., Guminski, A., Foley, P., Chang, A. S., Lewis, K., Squittieri, N., Loquai, C. MOSBY-ELSEVIER. 2021: AB89

View details for Web of Science ID 000683887500348